G2TT
来源类型Report
规范类型报告
来源IDRR-763-CMS
Specialty Payment Model Opportunities and Assessment: Oncology Model Design Report
Peter J. Huckfeldt; Chris Chan; Samuel Hirshman; Aaron Kofner; Jodi L. Liu; Andrew W. Mulcahy; Ioana Popescu; Clare Stevens; Justin W. Timbie; Peter S. Hussey
发表日期2015-03-17
出版年2015
页码226
语种英语
结论 Specialty Payment Model Opportunities and Assessment: Oncology Model Design Report | RAND
摘要

This report describes research related to the design of a payment model for specialty oncology services for possible testing by the Center for Medicare and Medicaid Innovation at the Centers for Medicare & Medicaid Services (CMS). Cancer is a common and costly condition. Episode-based payment, which aims to create incentives for high-quality, low-cost care, has been identified as a promising alternative payment model for oncology care. Episode-based payment systems can provide flexibility to health care providers to select among the most effective and efficient treatment alternatives, including activities that are not currently reimbursed under Medicare payment policies. However, the model design also needs to ensure that high-quality care is delivered and that beneficial treatments are not withheld from patients. CMS asked MITRE and RAND to conduct analyses to inform design decisions related to an episode-based oncology model for Medicare beneficiaries undergoing chemotherapy treatment for cancer. In particular, this report focuses on analyses of Medicare claims data related to the definition of the initiation of an episode of chemotherapy, patterns of spending during and surrounding episodes of chemotherapy, and attribution of episodes of chemotherapy to physician practices. We found that the time between the primary cancer diagnosis and chemotherapy initiation varied widely across patients, ranging from one day to over seven years, with a median of 2.4 months. The average level of total monthly payments varied considerably across cancers, with the highest spending peak of $9,972 for lymphoma, and peaks of $3,109 for breast cancer and $2,135 for prostate cancer.

目录
  • Chapter One

    Background

  • Chapter Two

    Methods

  • Chapter Three

    Definition of an Episode of Chemotherapy

  • Chapter Four

    Spending Patterns for Chemotherapy Treatment and Implications for SavingsOpportunities

  • Chapter Five

    Attribution of Episodes to Practices

主题Bundled Payment for Health Services ; Cancer Treatment ; Medicaid ; Medicare ; United States
URLhttps://www.rand.org/pubs/research_reports/RR763.html
来源智库RAND Corporation (United States)
资源类型智库出版物
条目标识符http://119.78.100.153/handle/2XGU8XDN/522706
推荐引用方式
GB/T 7714
Peter J. Huckfeldt,Chris Chan,Samuel Hirshman,et al. Specialty Payment Model Opportunities and Assessment: Oncology Model Design Report. 2015.
条目包含的文件
文件名称/大小 资源类型 版本类型 开放类型 使用许可
RAND_RR763.pdf(2717KB)智库出版物 限制开放CC BY-NC-SA浏览
x1495316206271.jpg.p(2KB)智库出版物 限制开放CC BY-NC-SA浏览
个性服务
推荐该条目
保存到收藏夹
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Peter J. Huckfeldt]的文章
[Chris Chan]的文章
[Samuel Hirshman]的文章
百度学术
百度学术中相似的文章
[Peter J. Huckfeldt]的文章
[Chris Chan]的文章
[Samuel Hirshman]的文章
必应学术
必应学术中相似的文章
[Peter J. Huckfeldt]的文章
[Chris Chan]的文章
[Samuel Hirshman]的文章
相关权益政策
暂无数据
收藏/分享
文件名: RAND_RR763.pdf
格式: Adobe PDF
文件名: x1495316206271.jpg.pagespeed.ic.2un0RIfRnX.jpg
格式: JPEG

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。